MX2018011121A - Prevención de la adherencia de tejido biológico. - Google Patents

Prevención de la adherencia de tejido biológico.

Info

Publication number
MX2018011121A
MX2018011121A MX2018011121A MX2018011121A MX2018011121A MX 2018011121 A MX2018011121 A MX 2018011121A MX 2018011121 A MX2018011121 A MX 2018011121A MX 2018011121 A MX2018011121 A MX 2018011121A MX 2018011121 A MX2018011121 A MX 2018011121A
Authority
MX
Mexico
Prior art keywords
biological tissue
self
tissue adhesion
assembling peptide
adhesion
Prior art date
Application number
MX2018011121A
Other languages
English (en)
Inventor
Kobayashi Satoru
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of MX2018011121A publication Critical patent/MX2018011121A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00818—Treatment of the gastro-intestinal system
    • A61B2017/00823—Appendectomy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831—Material properties
    • A61B2017/00893—Material properties pharmaceutically effective

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

En la presente se describen métodos y materiales para mitigar la adherencia de tejidos biológicos. Un método para mitigar la adherencia a un tejido biológico incluye administrar una cantidad efectiva de una solución de péptido autoensamblante al tejido biológico, en donde el péptido autoensamblante tiene entre 7 aminoácidos y 32 aminoácidos de longitud, y la solución de péptido autoensamblante forma un hidrogel en condiciones fisiológicas.
MX2018011121A 2016-03-18 2017-03-17 Prevención de la adherencia de tejido biológico. MX2018011121A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662310121P 2016-03-18 2016-03-18
US201662310131P 2016-03-18 2016-03-18
PCT/IB2017/000312 WO2017158420A1 (en) 2016-03-18 2017-03-17 Preventing biological tissue adhesion

Publications (1)

Publication Number Publication Date
MX2018011121A true MX2018011121A (es) 2019-01-31

Family

ID=58645327

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011121A MX2018011121A (es) 2016-03-18 2017-03-17 Prevención de la adherencia de tejido biológico.

Country Status (11)

Country Link
US (3) US20190091376A1 (es)
EP (1) EP3429653B1 (es)
JP (1) JP7049557B2 (es)
KR (1) KR20190022455A (es)
CN (1) CN109152868A (es)
AU (2) AU2017232540A1 (es)
BR (1) BR112018068941A2 (es)
CA (1) CA3017684A1 (es)
CL (1) CL2018002646A1 (es)
MX (1) MX2018011121A (es)
WO (1) WO2017158420A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112368295A (zh) 2018-07-03 2021-02-12 立美基股份有限公司 离子性自组装肽
JP7335025B2 (ja) 2020-03-31 2023-08-29 株式会社スリー・ディー・マトリックス 照射による自己組織化ペプチドの滅菌

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4049671A1 (en) * 2004-07-06 2022-08-31 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
EP1879606B1 (en) * 2005-04-25 2013-06-12 Massachusetts Institute of Technology Self-assembling peptides for promoting hemostasis
BRPI0920030B1 (pt) * 2008-10-06 2019-03-26 3-D Matrix, Ltd. Agente de oclusão do tecido, agentes hemostáticos, preventivos e de oclusão ou escleroterapia relacionados, e infusão do tecido mucosal
EP2750687B1 (en) * 2011-09-02 2017-12-06 3-D Matrix, Ltd. Amphiphilic peptides for thoracic air leakage occlusion
JP2016501066A (ja) * 2012-11-14 2016-01-18 株式会社スリー・ディー・マトリックス 血管塞栓システム
WO2014141160A1 (en) * 2013-03-14 2014-09-18 3-D Matrix, Ltd Treatment for bile leakage

Also Published As

Publication number Publication date
KR20190022455A (ko) 2019-03-06
CA3017684A1 (en) 2017-09-21
JP7049557B2 (ja) 2022-04-07
AU2021225225A1 (en) 2021-09-30
JP2019508184A (ja) 2019-03-28
WO2017158420A1 (en) 2017-09-21
BR112018068941A2 (pt) 2019-04-16
CL2018002646A1 (es) 2019-07-05
CN109152868A (zh) 2019-01-04
US20220111126A1 (en) 2022-04-14
AU2017232540A1 (en) 2018-09-27
US20230241294A1 (en) 2023-08-03
US20190091376A1 (en) 2019-03-28
EP3429653B1 (en) 2022-11-09
EP3429653A1 (en) 2019-01-23

Similar Documents

Publication Publication Date Title
PH12019501414A1 (en) Amino acid compositions and methods for the treatment of liver diseases
MX2019011215A (es) Ácidos nucleicos que codifican proteínas asociadas a crispr y usos de los mismos.
PH12020500321A1 (en) Amino acid compositions for the treatment of liver disease
MX2018011120A (es) Oclusion de fistula pancreatica.
MX2021007434A (es) Peptidos de colageno producidos de forma sintetica y recombinante con eficacia biologica.
EP3501532A3 (en) Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
MX2021008207A (es) Proteínas de fusión multifuncionales y usos de las mismas.
WO2019045248A3 (ko) 주름 개선 활성을 나타내는 펩타이드 및 이의 용도
AU2018236629A8 (en) Hydrogel patch
MX2019001633A (es) Proteina derivada de la seda para el tratamiento de la inflamacion.
WO2018068947A3 (de) Proteinhydrolysate
MX2018011121A (es) Prevención de la adherencia de tejido biológico.
PH12017501304A1 (en) Levodopa and carbidopa intestinal gel and method of use
WO2018060528A3 (en) Therapeutic protein
EP3590338A3 (en) Medical treatments based on anamorelin
WO2019043649A3 (en) ANGIO -3 FOR THE TREATMENT OF RETINAL ANGIOGENIC DISEASES
MX2022014577A (es) Gel intestinal de levodopa y carbidopa y metodos de uso.
WO2019055776A3 (en) Compositions and methods for treatment of diseases involving cxcl1 function
WO2018209358A3 (en) Systemic delivery of polypeptides
MX2018011082A (es) Péptido o aminoácido n-lipoico, derivados y sus usos.
MX2018011201A (es) Oclusion de fuga de liquido cefalorraquideo.
EP4257128A3 (en) Methods and compounds for the treatment of genetic disease
EP4074818A3 (en) Tissue organoids
MX2022012371A (es) Peptido o aminoacido n-lipoico, derivados y sus usos.
EP4155734A3 (en) Method